Aurobindo Pharma recorded a 2.59 per cent fall in its net profit to Rs 76.08 crore for the quarter ended March 31, 2008 compared to Rs 78.1 crore during the same period last year. Its income for the quarter under consideration increased by 21.91 per cent to Rs 641.27 crore compared to Rs 525.99 crore last year. Its expenditure increased by 16.74 per cent to Rs 550.87 crore compared to Rs 471.86 crore in the corresponding quarter previous year. The earnings per share for the quarter stood at Rs 14.15 this year from Rs 14.64 last year. According to Aurobindo corporate finance advisor A K Kamath, the profit of the fourth quarter of 2007-08 is not comparable with the corresponding quarter of last year. In the fourth quarter of 2006-07, there was no provision for taxation as a deferred tax of Rs 23.35 crore had been reversed and adjusted in the books. On the other hand, an amount of Rs 9.94 crore was provided towards taxation in the last quarter of 2007-08. He said that the exchange fluc...
This is my investment scrapbook. My request to viewers would be to use their own judgment before taking call on any shares mentioned here. Moreover, although I always try to be accurate and correct , there is no guarantee of the accuracy and correctness of the information provided here. Viewers would be using information provided here at their own risk. I won't be liable for any loss whatsoever for transaction based on the information provided here.